TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of TESARO, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. TESARO, Inc. market cap is N/A.
What is the 52-week high for TESARO, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. TESARO, Inc. 52 week high is N/A as of September 07, 2025.
What is the 52-week low for TESARO, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. TESARO, Inc. 52 week low is N/A as of September 07, 2025.
What is TESARO, Inc. stock price today?
TESARO, Inc. stock price today is $74.96.
What was TESARO, Inc. stock price yesterday?
TESARO, Inc. stock price yesterday was $74.94.
What is the PE ratio of TESARO, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. TESARO, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of TESARO, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. TESARO, Inc. P/B ratio is None.
What is TESARO, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. TESARO, Inc.'s EBITDA is -3.79.
What is the 50-day moving average of TESARO, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. TESARO, Inc. 50-day moving average is N/A.
